ValenTx
OverviewSuggest Edit
ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. It offers a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in least-invasive therapy.
| Type | Private | |
| Founded | 2002 | |
| Website | valentx.com |
Latest Updates
| Employees (est.) (Sep 2019) | 16 |
ValenTx Financials and Metrics
Summary Metrics
Founding Date | 2002 |
ValenTx total Funding | $38.1 m |
ValenTx latest funding size | $10.30 m |
Time since last funding | a year ago |
ValenTx investors | Kaiser Permanente Ventures, EDF Ventures, Affinity Capital Management, Covidien Ventures, SV Health Investors |
ValenTx's latest funding round in August 2018 was reported to be $10.3 m. In total, ValenTx has raised $38.1 m
ValenTx Online and Social Media Presence
ValenTx's Trends
ValenTx Frequently Asked Questions
When was ValenTx founded?
ValenTx was founded in 2002.
How many employees does ValenTx have?
ValenTx has 16 employees.
Who are ValenTx competitors?
Competitors of ValenTx include Tactile Medical, E-Qure and Novian Health.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies